Syntara (ASX:SNT) Ending Cash Position : A$5.69 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Syntara Ending Cash Position?

Syntara's Ending Cash Position for the quarter that ended in Dec. 2023 was A$5.69 Mil.

Syntara's quarterly Ending Cash Position declined from Dec. 2022 (A$16.45 Mil) to Jun. 2023 (A$9.23 Mil) and declined from Jun. 2023 (A$9.23 Mil) to Dec. 2023 (A$5.69 Mil).

Syntara's annual Ending Cash Position declined from Jun. 2021 (A$18.71 Mil) to Jun. 2022 (A$8.94 Mil) but then increased from Jun. 2022 (A$8.94 Mil) to Jun. 2023 (A$9.23 Mil).

Syntara Ending Cash Position Historical Data

The historical data trend for Syntara's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara Ending Cash Position Chart

Syntara Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

31.12

14.76

18.71

8.94

9.23

Syntara Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															20.87	8.94	16.45	9.23	5.69

Syntara Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Syntara's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8.937	+	0.293
	=	9.23

Syntara's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9.23	+	-3.536
	=	5.69

Syntara Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Syntara's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Syntara (ASX:SNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

UUDA:Germany

Address

20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086

Website

https://www.pharmaxis.com.au

Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.